Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FBGQR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,012
Award facts
- Contract value 100% obligated
- $11,011.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Stelara (ustekinumab) 45 mg/0.5 mL syringes with a ceiling value of $11,011.89. This is a firm fixed price delivery order with no set-aside designation, requiring completion by September 25, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated its capability to meet federal procurement requirements through competitive awards across its extensive portfolio of medical product deliveries with the Defense Logistics Agency and Medical Supply Chain. Through the DLA Troop Support Medical IDC, AmerisourceBergen supplies specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FBGQR?
SPE2DB25FBGQR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FBGQR worth?
The government has obligated $11,012 on SPE2DB25FBGQR.
Is contract SPE2DB25FBGQR an order under another contract?
Yes. SPE2DB25FBGQR is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBGQR competed?
The extent of competition for SPE2DB25FBGQR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award